Evidence map›Paper›PMID 32751609›Full record

ArticleMicroorganisms2020

Forecasting the Spreading of COVID-19 across Nine Countries from Europe, Asia, and the American Continents Using the ARIMA Models.

Ovidiu-Dumitru Ilie, Roxana-Oana Cojocariu, Alin Ciobica, Sergiu-Ioan Timofte, Ioannis Mavroudis, Bogdan Doroftei

Abstract read
In one paragraph

Article in Microorganisms, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Application of an ARFIMA Model to Estimate Hepatitis C Epidemics in Henan, China.The American journal of tropical medicine and hygiene · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Comparison of ARIMA, ETS, NNAR, TBATS and hybrid models to forecast the second wave of COVID-19 hospitalizations in Italy.The European journal of health economics : HEPAC : health economics in prevention and care · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. COVID-19 epidemic outside China: 34 founders and exponential growth.Journal of investigative medicine : the official publication of the American Federation for Clinical Research · 2021
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ovidiu-Dumitru IlieDepartment of Research, Faculty of Biology, "Alexandru Ioan Cuza" University, 700505 Iasi, Romania.ORCID 0000-0002-4023-1765
Roxana-Oana CojocariuDepartment of Research, Faculty of Biology, "Alexandru Ioan Cuza" University, 700505 Iasi, Romania.
Alin CiobicaDepartment of Research, Faculty of Biology, "Alexandru Ioan Cuza" University, 700505 Iasi, Romania.
Sergiu-Ioan TimofteDepartment of Biology, Faculty of Biology, "Alexandru Ioan Cuza" University, 700505 Iasi, Romania.ORCID 0000-0001-6155-2296
Ioannis MavroudisLeeds Teaching Hospitals NHS Trust, Great George St., Leeds LS1 3EX, UK.
Bogdan DorofteiFaculty of Medicine, University of Medicine and Pharmacy "Grigore T. Popa", 700115 Iasi, Romania.

Funding

UEFISCDI PN-III-P1-1.1-TE-2016-1210
6 · The paper itself

Abstract

Since mid-November 2019, when the first SARS-CoV-2-infected patient was officially reported, the new coronavirus has affected over 10 million people from which half a million died during this short period. There is an urgent need to monitor, predict, and restrict COVID-19 in a more efficient manner. This is why Auto-Regressive Integrated Moving Average (ARIMA) models have been developed and used to predict the epidemiological trend of COVID-19 in Ukraine, Romania, the Republic of Moldova, Serbia, Bulgaria, Hungary, USA, Brazil, and India, these last three countries being otherwise the most affected presently. To increase accuracy, the daily prevalence data of COVID-19 from 10 March 2020 to 10 July 2020 were collected from the official website of the Romanian Government GOV.RO, World Health Organization (WHO), and European Centre for Disease Prevention and Control (ECDC) websites. Several ARIMA models were formulated with different ARIMA parameters. ARIMA (1, 1, 0), ARIMA (3, 2, 2), ARIMA (3, 2, 2), ARIMA (3, 1, 1), ARIMA (1, 0, 3), ARIMA (1, 2, 0), ARIMA (1, 1, 0), ARIMA (0, 2, 1), and ARIMA (0, 2, 0) models were chosen as the best models, depending on their lowest Mean Absolute Percentage Error (MAPE) values for Ukraine, Romania, the Republic of Moldova, Serbia, Bulgaria, Hungary, USA, Brazil, and India (4.70244, 1.40016, 2.76751, 2.16733, 2.98154, 2.11239, 3.21569, 4.10596, 2.78051). This study demonstrates that ARIMA models are suitable for making predictions during the current crisis and offers an idea of the epidemiological stage of these regions.

Indexed as

AsiaCOVID-19epidemiologicalEuropeincidenceprevalenceSARS-CoV-2the American continents

Identifiers

PMID32751609
PMCPMC7463904

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.